Advertisement

Goodbye, Pharmalot

The popular blog covering pharmaceutical and biotech industry news has been shuttered.  

By | January 2, 2014

WIKIMEDIA, KEN HAWKINSEach day, Ed Silverman, a long-time blogger and reporter, would start his morning post on Pharmalot with the chipper greeting, “Pharmalot, Pharmalittle,” plus a few words on the weather and whatever else was on his mind. For years, Silverman covered the ins and outs of the biotech and pharmaceutical industries on his popular blog. But as of December 31, Pharmalot’s parent company, UBM Canon, shut down production of Med Ad News, eKnowledgeBase, R&D Directions, and PharmaLive.com—which hosted Silverman’s blog.

“Everyone in the Pharma Blogosphere was surprised and saddened by this announcement,” wrote PharmaGuy at Pharma Marketing Blog. Silverman “will especially be missed as his voice and stories added insight to the complex and changing world of healthcare marketing,” wrote Richard Meyer at WorldofDTCMarketing.com. “We need people like Ed, John Mack and others to be the conscious [sic] of our industry and remind everyone that developing good products is good medicine which in turn means good business.”

The blog's archives are now inaccessible. In place of posts, Pharmalive.com/Pharmalot today donned a statement from UMB Canon: “Thank you for your loyalty and support that has played such an important part over the last thirty years.”

The author of the blog shearlingsplowed has appealed to readers to find ways to support Silverman’s work. “His thoughtful, careful and yet non-biased take—on all things life science—is a voice we cannot afford to see fall silent.”

On Twitter, Silverman said he won’t “disappear.” The Scientist has reached out to the blogger to find out where we might read him in the future and will update this post to reflect his response.

Update (January 2): Silverman wrote in an email to The Scientist: “My priority is keeping the lights on. And I hope to land another gig very soon that will allow me to continue the same sort of coverage.” He said readers can follow him on Twitter, @edsilverman and @pharmalot.

 

Advertisement

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: Paul Stein

Paul Stein

Posts: 130

January 3, 2014

UBM Canon, the behind-the-scenes overseer of much we all take for granted in the life sciences news world, has undergone some serious reorganization in the past year.  It's a business, folks, and UBM has dumped much that was simply viewed as not-so or unprofitable, some of which has come to light in this article.  

Avatar of: PBM Guy

PBM Guy

Posts: 1

January 7, 2014

Don't forget that part of UBM Canon's core business is providing marketing services to the pharmaceutical industries.  Ed reported the news whether it was flattering to pharma or not.  I doubt that helped his cause when the bean-counters made the decision to cut him.

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
LI-COR Biosciences
LI-COR Biosciences
Advertisement
Life Technologies